Get the Weekly Intelligence Brief — top committee picks every Sunday.

ACAD vs MTD

ACADIA Pharmaceuticals Inc. vs Mettler Toledo — AI-powered side-by-side comparison
ACAD
ACADIA Pharmaceuticals Inc.
61
Buy
VS
MTD
Mettler Toledo
64
Buy
MetricACADMTD
AI Score 61 64
Price $30.59 $1,402.84
P/E Ratio 13.18× 31.43×
ROE 31.9% -3677.4%
Revenue Growth YoY
Gross Margin 91.1% 59.3%
Debt / Equity 0.06× 164.70×
Dividend Yield 0.0% 0.0%
RSI (14) 61.2 45.7
Beta 0.845 1.224
Expected Upside +7.9%

AI Committee View

Current Innellis committee reasoning for ACAD versus MTD.
MTD leads by 3 points.

MTD scores 64/100 (Buy) versus ACAD at 61/100 (Buy).

ACAD Committee View
60% agreement
5 analysts

The committee is genuinely divided. Growth Analyst sees a compelling case — quarter-over-quarter growth rate is accelerating, not just positive. Risk Analyst remains cautious — bollinger bandwidth of 21.2% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
  • Weekly RSI at 75 -- overbought on the larger timeframe too — Technical
  • Bollinger bandwidth of 21.2% signals elevated volatility — Risk
MTD Committee View
50% agreement
4 analysts

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ACAD Full Analysis MTD Full Analysis